Average US movie ticket priceNovo Nordisk semaglutide (Ozempic/Wegovy) revenue
The average US movie ticket price and Novo Nordisk's semaglutide revenue have, between 2018 and 2023, risen together at a correlation of 0.925. The implication that the weight-loss drug is driving up ticket prices — or vice versa — is entirely unsupported. Both numbers simply went up during the same six years. Lots of numbers did.
US movie ticket prices climbed from around $9 to over $11 in the period. Novo Nordisk's semaglutide revenue exploded from near zero to over $25 billion in the same window as Ozempic and Wegovy became generational pharmaceutical phenomena. Both trends reflect the same decade of expanding discretionary and medical spending, with premium categories in both entertainment and pharmaceuticals growing aggressively. The theater and the injection have no shared board. Both are selling into the same expanding consumer budget.
Six years of two lines rising together can describe two premium categories scaling in parallel. The seat and the prescription are both more expensive. The wallet has not grown.
As an Amazon Associate, getspurious.com earns from qualifying purchases. Learn more.
Want to learn more about why correlations like “Average US movie ticket price” vs “Novo Nordisk semaglutide (Ozempic/Wegovy) revenue” don't prove causation? Read our guide to statistical thinking.
